VULVAR ADENOCARCINOMA
Clinical trials for VULVAR ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new VULVAR ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for VULVAR ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo aims to fight Hard-to-Treat vulvar cancer
Disease control Recruiting nowThis phase 2 trial is testing whether combining two drugs, pembrolizumab and lenvatinib, can shrink tumors in people with vulvar cancer that cannot be removed by surgery. About 80 participants will receive the drugs in 21-day cycles. The study will measure how many patients respo…
Matched conditions: VULVAR ADENOCARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute, Naples • Aim: Disease control
Last updated Jun 23, 2026 22:17 UTC
-
New drug targets tumors from inside: early trial begins
Disease control Recruiting nowThis early-phase trial tests a new drug called AVA6103 in about 174 adults with advanced solid tumors (like pancreatic, lung, or breast cancer) that have not responded to standard treatments. The drug is designed to activate only inside tumors, aiming to kill cancer cells while l…
Matched conditions: VULVAR ADENOCARCINOMA
Phase: PHASE1 • Sponsor: Avacta Life Sciences Ltd • Aim: Disease control
Last updated Jun 10, 2026 13:24 UTC